Confirmed & Prior Speakers
Highlights from Miami CEO
View highlights from the 2025 Miami CEO and hear what makes the meeting so unique. Watch footage and hear testimonials from industry leaders at Miami CEO, including: Brent Saunders (Chair & CEO, Bausch + Lomb), Levi Garraway (CMO, Roche Genentech), Bill Mezzanotte (Global Head, R&D, CSL), Jeremy Levin (CEO, Ovid Therapeutics), Julie Gerberding (former Director, CDC), Greg Verdine (CEO, LifeMine Therapeutics), Jeff Aronin (CEO, Paragon Biosciences), and more.
Testimonial
Julie Gerberding
former Director, CDC;
CEO, Foundation for the NIH
“The topics really addressed the crazy environment in which we're all operating and brought all the dimensions together to focus the biotech ecosystem on not only what the problems are, but what the opportunities are, and I think all of us are leaving with a little bit more hope.”
Agenda
6:30 - 9:30 pm
WELCOME RECEPTION
Wednesday, March 11
7:00 - 8:00 am
NETWORKING BREAKFAST
8:00 - 11:00 am
OFF-THE-RECORD DISCUSSION PANELS
11:30 am - 2:30 pm
LUNCHEON ON THE BEACH
6:00 pm
SUNSET COCKTAILS AND DINNER OVERLOOKING MIAMI HARBOR AT THE KEY BISCAYNE YACHT CLUB
Thursday, March 12
7:00 - 8:00 am
NETWORKING BREAKFAST
8:00 - 11:00 am
OFF-THE-RECORD DISCUSSION PANELS
11:00 am
MIMOSA SEND-OFF
Friday, March 13
Miami CEO is hosted at The Ritz-Carlton Key Biscayne, Miami.
The Ritz-Carlton Key Biscayne, Miami
455 Grand Bay Drive
Miami, Florida, 33149
The Ritz-Carlton Key Biscayne, Miami is located approximately 30 minutes from Miami International Airport.
Venue
Companies Represented
at Previous Miami CEO
23andMe
8 Prime
Abzena
Adimab
Affimed
Affini-T
Agios
Aitia
Akamis Bio
ALAFIA
Alexandria Real Estate Equities
Alliant
AlloVir
Alloy Therapeutics
Altesa Biosciences
AltruBio
American Cancer Society
ANeuroTech
Apellis Pharmaceuticals
Apogee Therapeutics
ArsenalBio
Ashvattha Therapeutics
Astellas
Bausch + Lomb
Be Bio
BenchSci
BFlexion
BIO (Biotechnology Industry Organization)
bit.bio
Bitterroot Bio
Blackstone Life Science
Bluejay Therapeutics
BlueRock Therapeutics
Bonito Biosciences
Boston Properties
Boundless Bio
Braeburn
BreakBio
Cadrenal Therapeutics
Cain Global Partners
Cambrian Biopharma
Candel Therapeutics
Carbon Biosciences
Caris Life Sciences
Caszyme
Catalent
Catalyst Advisors
Cerevance
Cirius Therapeutics
CNS Pharmaceuticals
Code Bio
Collegium Pharmaceutical
Corner Therapeutics
CSL
CureDuchenne
Curie.Bio
Cytiva
Danaher Corporation
Deerfield Management
Define Ventures
Deka Biosciences
Delta Life Sciences
Dualitas
Dyne Therapeutics
Editas Medicine
Eledon Pharmaceuticals
EMD Serono
Engrail Therapeutics
Entact Bio
Eratos Therapeutics
Evommune
Exelixis
Exuma Biotech
Eyepoint Pharmaceuticals
Flagship Pioneering
Foley Hoag
Foresee Pharmaceuticals
Formation Bio
Foundation for the NIH
Founders Fund
Fractyl
Gallop Oncology
Generian
Genetix Biotherapeutics
GHO Capital Partners
Gilgamesh Pharmaceutical
Ginkgo Bioworks
GlycoEra
Gradalis
Graviton Bio
H1
Hansa Biopharma
Healthcare Royalty Partners
HealthQuest Capital
Herophilus
Herringbone & Brass
IGI
Immunitas
Immunoprecise Antibodies
Intrexon Corporation
Ipsen
IQVIA
Ironwood Pharmaceuticals
Jeito Capital
Johnson & Johnson
JPM Private Capital
Karuna Therapeutics
Karyopharm Therapeutics
Klick
Lilly
Longwood Fund
Lumanity
Lumen Bioscience
Lundbeck
Lupin
Mammoth
Marengo Therapeutics
Mass General Brigham
MassBio
Matrix Capital
Medable
Medicilon
Merrill Lynch
MetroBiotech
Mimetic Medicines
Mintz
Mongoose Bio
Morphoceuticals
MPM BioImpact
MResult
Multiple Myeloma Research Foundation
Myris Therapeutics
Nan Fung
NanoCell Therapeutics
NAYA Therapeutics
Neurocentria
Neurocrine Biosciences
New Enterprise Associates
Normunity
Novartis
Nvelop Therapeutics
Ochre Bio
Octant
Odgers Berndtson
Opus Genetics
Orano Med
Origenis GmbH
Orna Therapeutics
Ovid Therapeutics
Parabilis Medicines
Paragon Biosciences
Parexel
Pfizer
Phanes Therapeutics
Pivotal Life Sciences
Portal Instruments
Precede Biosciences
Precision BioSciences
Precision for Medicine
Premji Invest
PriveBio
ProFound Therapeutics
Project Prometheus
ProMIS Neurosciences
Protego Biopharma
Pulmocide
Pyxis Oncology
Qilu Pharmaceutical
Quanterix
QurAlis
Radiant Biotherapeutics
Rallybio
Rectify Pharmaceuticals
Recursion
Regeneron
Regeneron Ventures
REGENXBIO
Replicor
Roche
Roivant Sciences
Royalty Pharma
Saghmos Therapeutics
Sarepta Therapeutics
SELLAS Life Sciences Group
Skye Bioscience
Sofinnova
Solu Therapeutics
Spirovant Sciences
Starton Therapeutics
Stifel Financial Corporation
Stipple Bio
Summit Therapeutics
Supernus Pharmaceutical
Syndeio Biosciences
Tane Pharmaceuticals, Inc.
Taron Solutions
Tolerance Bio
TPG
TRexBio
Trio Pharmaceuticals
TScan Therapeutics
Twain Therapeutics
Unicycive
Unipr
Uniquity Bio
University Health Network
University of Miami
VectorY Therapeutics
Verastem
Vertex Ventures
Verve Therapeutics
VidaVinci
Viking Global Investors
Volastra Therapeutics
Vor Biopharma
Voyager Therapeutics
Weaver
WuXi AppTec
Xilio Therapeutics
XyloCor
Zai Lab
ZRG Partners
